50. S.S. Jurisson, J.D. Lydon, Potential technetium small molecule radiopharmaceuticals. Chem.
Rev. (U. S.) 99(9), 2205–2218 (1999)
51. D.W. Wong, A. Mandal, I.C. Reese, J. Brown, R. Siegler, In vivo assessment of
99m
Tc-labeled hematoporphyrin derivative in tumor-bearing animals. Int. J. Nucle. Med.
Biol. 10(4), 211–218 (1983)
52. A.-Y. Wang, J.-L. Lin, W.-C. Lin, Studies on the porphine labeled with 99 mTc–
pertechnetate. J. Radioanal. Nucl. Chem. 284(1), 21–28 (2010)
53. S. Shetty, S. Murugesan, S. Chatterjee, S. Banerjee, T. Srivastava, O.P. Noronha et al., A new
99m
Tc labeled porphyrin for specific imaging of Sarcoma 120: Synthesis and biological study
in a Swiss mouse model. J. Label. Comp. Radiopharm. 38(5), 411–418 (1996)
54. S.R. Chatterjee, S. Murugesan, J. Kamat, S. Shetty, T. Srivastava, O. Noronha et al.,
Photodynamic effects induced by meso-tetrakis (4-(carboxymethyleneoxy) phenyl) porphyrin
using rat hepatic microsomes as model membranes. Arch. Biochem. Biophys. 339(1), 242–
249 (1997)
55. D.W. Wong, A. Mandal, I.C. Reese, J. Brown, R. Siegler, In vivo assessment of
99m
Tc-labeled hematoporphyrin derivative in tumor-bearing animals. Int. J. Nucl. Med.
Biol. 10(4), 211–218 (1983)
56. J.-H. Lee, S. Shao, K.T. Cheng, J.F. Lovell, C.H. Paik,
99m
Tc-labeled porphyrin–lipid
nanovesicles. J. Liposome Res. 25(2), 101–106 (2015)
57. S. Murugesan, S. Shetty, T. Srivastava, O. Noronha, A. Samuel, A technetium-99m-labelled
cyclam acid porphyrin (CAP) for tumour imaging. Appl. Radiat. Isot. 55(5), 641–646 (2001)
58. M. Subbarayan, S.J. Shetty, T.S. Srivastava, O.P. Noronha, A.M. Samuel, H. Mukhtar,
Water-soluble
99m Tc-labeled dendritic novel porphyrins tumor imaging and diagnosis.
Biochem. Biophys. Res. Commun. 281(1), 32–36 (2001)
59. M. Subbarayan, S. Shetty, T. Srivastava, O. Noronha, A. Samuel, Evaluation studies of
technetium-99m-porphyrin (T3, 4BCPP) for tumor imaging. J. Porphyr. Phthalocyanines. 5
(12), 824–828 (2001)
60. Y. Liu, B. Shen, F. Liu, B. Zhang, T. Chu, J. Bai et al., Synthesis, radiolabeling,
biodistribution and fluorescent imaging of histidine-coupled hematoporphyrin. Nucl. Med.
Biol. 39(4), 579–585 (2012)
61. R.A. Fawwaz, W. Hemphill, H. Winchell, Potential use of
109
Pd-porphyrin complexes for
selective lymphatic ablation. J. Nucl. Med. 12(5), 231–236 (1971)
62. R. Fawwaz, F. Frye, W. Loughman, W. Hemphill, Survival of skin homografts in dogs
injected with
109 Pd-protoporphyrin. J. Nucl. Med. 15(11), 997–1002 (1974)
63. S. Chakraborty, T. Das, S. Banerjee, H. Sarma, M. Venkatesh, Preparation and preliminary
biological evaluation of a novel
109
Pd labeled porphyrin derivative for possible use in targeted
tumor therapy. Q. J. Nucl. Med. Mol. Imaging 51(1), 16 (2007)
64. T. Das, S. Chakraborty, H. Sarma, S. Banerjee, A novel (
109
Pd) palladium labeled porphyrin
for possible use in targeted radiotherapy. Radiochim. Acta 96(7), 427–433 (2008)
65. D.W. Wong, A. Mandal, J. Brown, I.C. Reese, R. Siegler, S. Hyman, In vivo assessment of
111
In-labeled hematoporphyrin derivative in breast tumor-bearing animals. Int. J. Rad. Appl.
Instrum. B. 16(3), 269–281 (1989)
66. G. Robinson Jr., A. Alavi, R. Vaum, M. Staum, Imaging of lymph node uptake after
intravenous administration. J. Nucl. Med. 27, 239 (1986)
67. C. Ljungquist, Delineation of a transplanted malignant melanoma with indium-111-labeled
porphyrin. J. Nucl. Med. 26, 756–760 (1985)
68. S. Nakajima, H. Yamauchi, I. Sakata, H. Hayashi, K. Yamazaki, T. Maeda et al.,
111
In-labeled
Mn-metalloporphyrin for tumor imaging. Nucl. Med. Biol. 20(2), 231–237 (1993)
69. C.H. Bedel-Cloutour, L. Mauclaire, A. Saux, M. Pereyre, Syntheses of functionalized indium
porphyrins for monoclonal antibody labeling. Bioconjug. Chem. 7(6), 617–627 (1996)
70. R. Firestone, V. Shirley, C. Baglin, S. Chu, J. Zipkin, Table of Isotopes (A Wiley-Interscience
Publication. Wiley, New York, 1996)
76
V. Rajendiran et al.
Rev. (U. S.) 99(9), 2205–2218 (1999)
51. D.W. Wong, A. Mandal, I.C. Reese, J. Brown, R. Siegler, In vivo assessment of
99m
Tc-labeled hematoporphyrin derivative in tumor-bearing animals. Int. J. Nucle. Med.
Biol. 10(4), 211–218 (1983)
52. A.-Y. Wang, J.-L. Lin, W.-C. Lin, Studies on the porphine labeled with 99 mTc–
pertechnetate. J. Radioanal. Nucl. Chem. 284(1), 21–28 (2010)
53. S. Shetty, S. Murugesan, S. Chatterjee, S. Banerjee, T. Srivastava, O.P. Noronha et al., A new
99m
Tc labeled porphyrin for specific imaging of Sarcoma 120: Synthesis and biological study
in a Swiss mouse model. J. Label. Comp. Radiopharm. 38(5), 411–418 (1996)
54. S.R. Chatterjee, S. Murugesan, J. Kamat, S. Shetty, T. Srivastava, O. Noronha et al.,
Photodynamic effects induced by meso-tetrakis (4-(carboxymethyleneoxy) phenyl) porphyrin
using rat hepatic microsomes as model membranes. Arch. Biochem. Biophys. 339(1), 242–
249 (1997)
55. D.W. Wong, A. Mandal, I.C. Reese, J. Brown, R. Siegler, In vivo assessment of
99m
Tc-labeled hematoporphyrin derivative in tumor-bearing animals. Int. J. Nucl. Med.
Biol. 10(4), 211–218 (1983)
56. J.-H. Lee, S. Shao, K.T. Cheng, J.F. Lovell, C.H. Paik,
99m
Tc-labeled porphyrin–lipid
nanovesicles. J. Liposome Res. 25(2), 101–106 (2015)
57. S. Murugesan, S. Shetty, T. Srivastava, O. Noronha, A. Samuel, A technetium-99m-labelled
cyclam acid porphyrin (CAP) for tumour imaging. Appl. Radiat. Isot. 55(5), 641–646 (2001)
58. M. Subbarayan, S.J. Shetty, T.S. Srivastava, O.P. Noronha, A.M. Samuel, H. Mukhtar,
Water-soluble
99m Tc-labeled dendritic novel porphyrins tumor imaging and diagnosis.
Biochem. Biophys. Res. Commun. 281(1), 32–36 (2001)
59. M. Subbarayan, S. Shetty, T. Srivastava, O. Noronha, A. Samuel, Evaluation studies of
technetium-99m-porphyrin (T3, 4BCPP) for tumor imaging. J. Porphyr. Phthalocyanines. 5
(12), 824–828 (2001)
60. Y. Liu, B. Shen, F. Liu, B. Zhang, T. Chu, J. Bai et al., Synthesis, radiolabeling,
biodistribution and fluorescent imaging of histidine-coupled hematoporphyrin. Nucl. Med.
Biol. 39(4), 579–585 (2012)
61. R.A. Fawwaz, W. Hemphill, H. Winchell, Potential use of
109
Pd-porphyrin complexes for
selective lymphatic ablation. J. Nucl. Med. 12(5), 231–236 (1971)
62. R. Fawwaz, F. Frye, W. Loughman, W. Hemphill, Survival of skin homografts in dogs
injected with
109 Pd-protoporphyrin. J. Nucl. Med. 15(11), 997–1002 (1974)
63. S. Chakraborty, T. Das, S. Banerjee, H. Sarma, M. Venkatesh, Preparation and preliminary
biological evaluation of a novel
109
Pd labeled porphyrin derivative for possible use in targeted
tumor therapy. Q. J. Nucl. Med. Mol. Imaging 51(1), 16 (2007)
64. T. Das, S. Chakraborty, H. Sarma, S. Banerjee, A novel (
109
Pd) palladium labeled porphyrin
for possible use in targeted radiotherapy. Radiochim. Acta 96(7), 427–433 (2008)
65. D.W. Wong, A. Mandal, J. Brown, I.C. Reese, R. Siegler, S. Hyman, In vivo assessment of
111
In-labeled hematoporphyrin derivative in breast tumor-bearing animals. Int. J. Rad. Appl.
Instrum. B. 16(3), 269–281 (1989)
66. G. Robinson Jr., A. Alavi, R. Vaum, M. Staum, Imaging of lymph node uptake after
intravenous administration. J. Nucl. Med. 27, 239 (1986)
67. C. Ljungquist, Delineation of a transplanted malignant melanoma with indium-111-labeled
porphyrin. J. Nucl. Med. 26, 756–760 (1985)
68. S. Nakajima, H. Yamauchi, I. Sakata, H. Hayashi, K. Yamazaki, T. Maeda et al.,
111
In-labeled
Mn-metalloporphyrin for tumor imaging. Nucl. Med. Biol. 20(2), 231–237 (1993)
69. C.H. Bedel-Cloutour, L. Mauclaire, A. Saux, M. Pereyre, Syntheses of functionalized indium
porphyrins for monoclonal antibody labeling. Bioconjug. Chem. 7(6), 617–627 (1996)
70. R. Firestone, V. Shirley, C. Baglin, S. Chu, J. Zipkin, Table of Isotopes (A Wiley-Interscience
Publication. Wiley, New York, 1996)
76
V. Rajendiran et al.